Rapid Diagnostic Test Kit VerifyNow Qualitative Assay Asprin Assay Whole Blood Sample CLIA Waived 10 Tests

Description

Features

The VerifyNow Aspirin Assay provides a simple measurement to determine whether or not a patient is responding to their aspirin therapy
The VerifyNow Aspirin Assay is a qualitative assay to aid in the detection of platelet dysfunction due to aspirin ingestion incitrated whole blood for the point of care or laboratory setting
By measuring the rate and extent of changes in light transmittance caused by platelets aggregating in whole blood samples, the VerifyNow System determines the level of platelet function in response to agonists that are specific to the pathways of various antiplatelet medications
This assay is not for use in patients with underlying congenital platelet abnormalities, patients with non-aspirin induced acquired platelet abnormalities or in patients receiving non-aspirin antiplatelet agents (may be used in patient s treated with selective COX-2 inhibitors, e.g., celecoxib (Celebrex®)
Time to results is 5 minutes (sample incubation required)
Samples should be treated as biohazardous material and handled accordingly
Store assay devices at 2°C to 25°C (36°-77°F)
Manufacturer # 85053-10
Brand Verifynow®
Manufacturer Accriva Diagnostics
Application Rapid Diagnostic Test Kit
CLIA Classification CLIA Waived
For Use With For VerifyNow® Instrument
Kit Contents Lyophilized Fibrinogen Coated Beads, Platelet Agonist, Peptide, Bovine Serum Albumin, Stabilizer and Buffer
Number of Tests 10 Tests
Reading Type Optical Detection Instrument
Sample Type Whole Blood Sample
Storage Requirements USP Controlled Room Temperature
Test Format Test Device
Test Name Asprin Assay
Type Qualitative Assay
UNSPSC Code 41116008

Additional Information